Student Work
Gene Therapy for Pompe Disease Using AAV9 and AAVB1 Encoding the GAA Gene
PublicPompe disease, a storage disease caused by a lack of lysosomal acid alpha-glucosidase (GAA), results in systemic lysosomal glycogen accumulation and respiratory and muscle destruction. We propose that viral gene therapy can lower glycogen accumulation and relieve symptoms in a GAA-/- mouse model. Two viruses were engineered to contain plasmids encoding GAA (AAVB1-GAA or AAV9-GAA), and were injected IV into 90-day old GAA-/- or WT mice. Preliminary data with respiratory, behavioral, and histological assays suggest that both vectors improve the survival and pathology.
- This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.
- Creator
- Publisher
- Identifier
- E-project-042617-181354
- Advisor
- Year
- 2017
- Sponsor
- Date created
- 2017-04-26
- Resource type
- Major
- Rights statement
Relations
- Dans Collection:
Contenu
Articles
La vignette | Titre | Visibilité | Embargo Release Date | actes |
---|---|---|---|---|
|
Samantha_Bircsak_MQP_Final.pdf | Public | Télécharger |
Permanent link to this page: https://digital.wpi.edu/show/7h149r311